Axogen, Inc. — Director's Dealing 2024

Jun 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2024-06-04

Reporting Person: Freitag Gregory Gene (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-04	Common Stock	M	11904	—	Acquired	283498	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-04	Restricted Stock Units	$	M	11904	Disposed		Common Stock (11904)	Direct

Footnotes

F1: Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock.

F2: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.